Analysis and Synthesis of GMP and Non-GMP Bulk Drugs and Pharmaceutical Formulations (2023) | Federal Compass

Free Market Report: Trends & Observations
Analysis and Synthesis of GMP and Non-GMP Bulk Drugs and Pharmaceutical Formulations (2023)


Prepare yourself for competition by understanding federal market trends. Is this the right pursuit for my organization? How is the government buying my product and services? Is there an upcoming recompete for future work?


Contracting Agency/Office
Health and Human Services»National Institutes of Health»National Cancer Institute
NAICS
325412 Pharmaceutical Preparation Manufacturing
Competition Set-Aside Type
NONE

Award Type
IDC
Award Date
04/10/2023
Expiration Date
04/09/2028
No. of Awards
4
No. of Offers
11

Obligations by Fiscal Year

prime obligations by fiscal year

Start Your Free Account Today

Gain Full Access to This Report and...
Contract Opportunities
Pipeline Management
Award Research
Funding Analysis
Partner Identification
Industry and Market Intel
Agency Spending Trends
Competitive Insights

Federal Compass is software designed for today’s federal market.

Explore how the right intel and process can help lead your team to greater success.

Create Free Account

Enjoy instant access to the Federal Compass platform

Contracting Resources